These findings highlight the potential of ACKR3 in lipid metabolism and suggest that ACKR3 may be a possible contributor to metabolic diseases, such as insulin resistance, obesity, and atherosclerosis, which remains to be validated in future studies. The gene discussed is ACKR3; the disease is obesity due to melanocortin 4 receptor deficiency.